Marion Gruffaz

Marion Gruffaz, PhD, currently serves as a Research and Development Scientist at FemtoDx, focusing on the development of Point of Care Diagnostics utilizing antibody detection on microchip technology since May 2018. Prior to this role, Marion served as a Postdoctoral Research Associate at the Keck School of Medicine of the University of Southern California from January 2014 to May 2018, leading four significant projects related to TLR4-mediated inflammation and the therapeutic potential of cytarabine against primary effusion lymphoma. Marion earned a PhD in Virology from Université Claude Bernard Lyon 1 in June 2013, with research on the immune response to Hepatitis B, and completed a Postdoctoral Fellowship in Cancerology and Virology at the University of Southern California from 2014 to 2018, building on a Master's degree in Immunology and Virology obtained at Université Paris Cité from 2007 to 2009.